期刊文献+

非瓣膜病房颤患者血清尿酸和超敏C反应蛋白水平的变化

The Change of Serum Uric Acid and Hypersensitive C-reactive Protein in Nonvalvular Atrial Fibrillation
下载PDF
导出
摘要 目的探讨非瓣膜病房颤患者血清尿酸(UA)及超敏C反应蛋白(hs-CRP)水平的变化,并探讨其临床意义。方法入选2012年12月—2013年6月该院心内科住院诊断为非瓣膜病房颤患者108例,持续性房颤50例,阵发性房颤58例,对照组为同期门诊体检窦性心律、既往无房颤病史患者50例作为对照组。测定血清UA、hs-CRP等相关指标,比较各组间血清中UA、hs-CRP水平的变化及两者之间的相关关系。结果房颤组血清UA、hs-CRP水平均高于对照组,且持续性房颤组高于阵发性房颤组,差异有统计学意义(P<0.05)。相关分析显示两者呈正相关。结论血清UA、hs-CRP水平的升高参与了房颤的发生及维持。 Objective To explore the change and clinical significance of serum uric acid (UA) and hypersensitive C-reactive pro-tein(hs-CRP) in nonvalvular atrial fibrillation. Methods 108 cases of patients admitted in Cardiovascular Department of The Peo-ple&#39;s Hospital of Jiyuan City and diagnosed as nonvalvular atrial fibrillation from December, 2012 to June, 2013 were enrolled, in-cluding 50 cases of persistent atrial fibrillation, and 58 cases of paroxysmal atrial fibrillation. 50 cases of patients with sinus rhythm and without the history of atrial fibrillation underwent physical examination in the outpatient during the same period were selected as the control group. The levels of serum UA, hs-CRP and other related indicators were measured. The change of serum UA, hs-CRP and the relation between the two were compared between the groups. Results The serum levels of UA and hs-CRP of the atrial fibrillation group were higher than those of the control group, even more, those of the persistent atrial fibrillation group were higher than those of the paroxysmal atrial fibrillation group, the differences were statistically significant (P〈0.05). Relation analysis showed that the serum level of uric acid and hypersensitive C-reactive protein were positively correlated. Conclusion The increased serum UA and hs-CRP were involved in the occurrence and maintenance of atrial fibrillation.
机构地区 济源市人民医院
出处 《中外医疗》 2014年第12期1-3,共3页 China & Foreign Medical Treatment
关键词 房颤 尿酸 超敏C反应蛋白 Atrial Fibrillation Uric Acid Hypersensitive C-reactive Protein
  • 相关文献

参考文献13

  • 1Mathew ST,Patel J,JosePh S.Atrial fibrillation:mechanistic insights and treatment options[J]. Eur J Intern Med, 2009,20(7) : 672-681.
  • 2Chung MK,Martin DO,Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflananatory mechanisms and per- sistenee of atrial flbrillation[J].Cireulation, 2001,104:2886.
  • 3Letsas KP, Korantzopoulos P, Filippatos GS,et al.Uric acid elevation in atrial fibrillation[J]. Hellenic J Cardiol, 2010,51(3):209-213.
  • 4Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibfiLlation[J].Circulation, 1997,96 (4) : 1180-1184.
  • 5Kim YH, Lim DS, Lee JH, et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans[J]. Exp Mol Med, 2003,35 (5):336-349.
  • 6盛力,李悦,李为民.氧化应激与心房颤动时的心房结构重构[J].中国心脏起搏与心电生理杂志,2007,21(5):459-461. 被引量:10
  • 7Issac TT,Dokainish H,Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation;a systematic review of the pub- lished data[J]. J Am Coil Cardiol, 2007,50(21 ):2021-2028.
  • 8Sautin YY, Johnson RJ. Uric acid: the oxidant- antioxidant paradox[J]. Nucleosides Nucleotides Nucleic Acids, 2008,27(6):608-619.
  • 9Carnes CA,Chung MK, Nakayama T,et al.Ascorbate attenuates atrial pacinginduced peroxynitrite formation and electrical remodeling and de- creases the incidence of postoperative atrial flbrillation[J].Circ Res,2001, 89 : E32-E38.
  • 10Gonzalez DR,Treuer A,Sun QA,et al.S-nitrosylation of cardiac ion channels [J].Cardiovasc Pharmacol, 2009,54: 188-195.

二级参考文献38

  • 1李悦,李为民,薛竟宜,王凤龙,韩薇,潘尚哈,杨树森,初杉.缬沙坦对心房快速起搏犬心房电、结构和功能重构的影响[J].中华心律失常学杂志,2005,9(6):453-454. 被引量:4
  • 2Korantzopoulos P,Kolettis T,Siogas K,et al.Atrial fibrillation and electrical remodeling:the potential role of inflammation and oxidative stress[J].Med Sci Monit,2003,9:RA225-229.
  • 3Chung-Chuan Chou,Peng-Sheng Chen.New Concepts in Atrial Fibrillation:Mechanism and Remodeling[J].Med Clin North Am,2008,92(1):53-63.
  • 4Van Wagoner DR,Nerbonne JM.Molecular basis of electrical remodeling in atrial fibrillation[J].J Mol Cell Cardiol,2000,32:1101-1117.
  • 5Kumagai K,Nakashima H,Saku K.The HMG-CoA reductase inhibittor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model[J].Cardiovasc Res,2004,62:105-111.
  • 6Shiroshita TA,Schram G,Lavoie J,et al.Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs[J].Circulation,2004,110 (16):2313-2319.
  • 7Carnes CA,Chung MK,Nakayama T,et al.Ascorbate attenuates atrial pacing induced peroxy-nitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation[J].Circ Res,2001,89 (6):E322-E38.
  • 8Eiichiro Yamamoto,Zhong-Fang Lai,Takuro Yamashita,et al.Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis[J].Hypertension,2006,24:2057-2069.
  • 9Carnes CA,Janssen PM,Ruehr ML,et al.Atrial glutathione content,calcium current and contractility[J].J Biol Chem,2007,282:28063-28073.
  • 10Sata N,Hamada N,Horinouchi T,et al.C-reactive protein and atrial fibrillation:is inflammation a consequence or a cause of atrial fibrillation?[J].Jph Heart J,2004,45:441-445.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部